3 patents
Utility
PD-L1-specific antibodies and methods of using the same
5 Dec 23
The present disclosure relates generally to antibodies and functional binding fragments thereof that bind to programmed death-ligand 1 (PD-L1).
Jonathan Belk, Nathan J. Sharkey, Leonid Gorelik
Filed: 13 Mar 20
Utility
PD-L1-SPECIFIC Antibodies and Methods of Using the Same
2 Sep 20
The present disclosure relates generally to antibodies and functional binding fragments thereof that bind to programmed death-ligand 1 (PD-L1).
Jonathan Belk, Nathan J. Sharkey, Leonid Gorelik
Filed: 12 Mar 20
Utility
PD-L1-specific antibodies and methods of using the same
16 Mar 20
The present disclosure relates generally to antibodies and functional binding fragments thereof that bind to programmed death-ligand 1 (PD-L1).
Jonathan Belk, Nathan J. Sharkey, Leonid Gorelik
Filed: 27 Jun 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first